# EDGAR Filing Document

**Accession Number:** 0001590695
**File Stem:** 0001753926-23-000150
**Filing Date:** 2023-2
**Character Count:** 7704
**Document Hash:** c99a881bcdc9855c9f057be942ae49b0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001753926-23-000150.hdr.sgml**: 20230214

**ACCESSION NUMBER**: 0001753926-23-000150

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20230120

**ITEM INFORMATION**: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

**FILED AS OF DATE**: 20230214

**DATE AS OF CHANGE**: 20230214

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TWINLAB CONSOLIDATED HOLDINGS, INC.
- **CENTRAL INDEX KEY:** 0001590695
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **IRS NUMBER:** 463951742
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-55181
- **FILM NUMBER:** 23627843

**BUSINESS ADDRESS:**
- **STREET 1:** 4800 T-REX AVENUE
- **STREET 2:** SUITE 305
- **CITY:** BOCA RATON
- **STATE:** FL
- **ZIP:** 33431
- **BUSINESS PHONE:** 561-443-5001

**MAIL ADDRESS:**
- **STREET 1:** 4800 T-REX AVENUE
- **STREET 2:** SUITE 305
- **CITY:** BOCA RATON
- **STATE:** FL
- **ZIP:** 33431

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MIRROR ME, INC.
- **DATE OF NAME CHANGE:** 20131031

tlcc-20230120.htm

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K CURRENT REPORT**

**Pursuant to Section 13OR15(d) of The Securities Exchange Act of 1934**

Date of Report (Date of earliest event reported):**<u>January 20, 2023</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u>**

---

| |
|:---|
| **TWINLAB CONSOLIDATED HOLDINGS, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Nevada** | **000-55181** | **46-3951742** |
| (State orotherjurisdiction ofincorporation) | (CommissionFileNumber) | (IRSEmployer IdentificationNo.) |

---

---

| | |
|:---|:---|
| **4800 T-Rex Avenue, Suite 225,Boca Raton,Florida** | **33431** |
| (Address of principalexecutiveoffices) | (Zip Code) |

---

---

| | |
|:---|:---|
| Registrant's telephone number, includingareacode | **(561)443-5301** |
| (Former name or former address, if changed since last report) | (Former name or former address, if changed since last report) |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<u>see</u> General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class  | Trading Symbol(s)  | Name of each exchange on which registered  |

---

IndicatebycheckmarkwhethertheregistrantisanemerginggrowthcompanyasdefinedinRule405oftheSecuritiesActof1933(§230.405ofthischapter)orRule12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter)

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Section 5 – Corporate Governance and Management**

**Item 5.02 &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.**

***Resignation of Director***

On January 20, 2023, via letter, Mr. B. Thomas Golisano informed the Board of Directors (the "Board") of Twinlab Consolidated Holdings, Inc. ("the Company") that he was resigning from the Board and the Board's Nominating/Corporate Governance Committee and Compensation Committee, effective immediately. His resignation is not a result of any disagreement with the Company.

Resignation of Chief Executive Officer and Director; Appointment of Interim Chief Executive Officer

On January 26, 2023, Mr. Craig Fabel resigned from his position as Chief Executive Officer of the Company and as a member of the Company's Board of Directors, member of the Board's Audit Committee, and any and all other office and director positions held with any of the Company's subsidiaries, effective immediately. The Board of Directors of the Company unanimously accepted Mr. Fabel's resignation and, on January 26, 2023, appointed Kyle Casey, the Company's current Chief Financial Officer, as Interim Chief Executive Officer, effective immediately. In his capacity as Interim Chief Executive Officer, Mr. Casey will succeed Mr. Fabel as the principal executive officer of the Company, while maintaining his position as the principal financial officer.

Mr. Casey, age 39, joined the Company in April 2019 and served as the Company's Controller prior to his appointment as interim Chief Financial Officer of the Company, effective October 8, 2019. He was appointed Chief Financial Officer on January 13, 2020. Before joining the Company, Mr. Casey was with Gulfstream Park Racetrack and Casino from December 2015 through November 2018, most recently serving as the Vice President of Finance. Prior to his employment with Gulfstream Park Racetrack and Casino, Mr. Casey served as Chief Auditing Officer for the Florida Department of Business and Professional Regulation from March 2014 through December 2015. Mr. Casey holds a Bachelor of Science in Accounting and Finance, as well as a Master of Science in Taxation, from Florida State University. Mr. Casey is a licensed Certified Public Accountant.

There are no arrangements or understandings between Mr. Casey and any other persons in connection with his appointment. There are no family relationships between Mr. Casey and any director or executive officer of the Company, and Mr. Casey is not a party to any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K under the Securities Act of 1933, as amended.

On January 26, 2023, at a special meeting of the Board of Directors of the Company, the Board of Directors of the Company discussed the modification of Mr. Casey's salary in recognition of his additional duties as Interim Chief Executive Officer. The Company has not entered into an employment agreement with Mr. Casey in his capacity as Interim Chief Executive Officer and Chief Financial Officer, but the Board of Directors of the Company unanimously approved that his compensation be modified so that, effective January 26, 2023, he will receive an annual base salary of $345,000, until such time as a permanent Chief Executive Officer is elected, at which time Mr. Casey's salary will revert to $290,000, his prior salary as Chief Financial Officer.

------

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **TWINLAB CONSOLIDATED HOLDINGS, INC.** | **TWINLAB CONSOLIDATED HOLDINGS, INC.** |
| Date: February 14, 2023 | By: | /s/ Kyle Casey |
|  |  | Kyle Casey |
|  |  | Interim Chief Executive Officer and Chief Financial Officer |

---